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Phthalates are a group of organic esters known
as indoor air pollutants. The most common
phthalate indoors is di(2-ethylhexyl) phthalate
(DEHP), which is widely used as plasticizer
(softener), for example, to render polyvinyl
chloride (PVC) more ﬂexible. A wide variety
of consumer products also contain DEHP,
such as ﬂooring and other building materials,
household furnishings, clothing, cosmetics
and personal care products, lubricants, waxes,
cleaning materials, and medical products
(Schettler 2006). Other phthalates commonly
found in house dust include n-butyl benzyl
phthalate (BBzP), di-n-butyl phthalate
(DnBP), diisobutyl phthalate (DIBP), and
diethyl phthalate (DEP) (Bornehag et al.
2005). Because phthalates are not covalently
bound to the plastic matrix, they vaporize
directly into the environment, where they can
accumulate and adhere to inhalable airborne
and sedimented dust particles. In several stud-
ies, the median DEHP concentrations in
common households ranged from 0.4 to 0.96
mg/g house dust (Bornehag et al. 2005; Butte
et al. 2001; Fromme et al. 2004; Kolarik et al.
2008; Pöhner et al. 1997).
Indoor air is an important pathway of
human environmental exposure to various
phthalates (Latini 2005). One of the potential
health concerns of phthalate exposure is the
development of asthma and allergies.
Emissions from the degradation of PVC ﬂoor-
ing materials evoke conjunctival, upper airway,
and pulmonary irritations (Jaakkola et al.
1999; Wieslander et al. 1999). In addition, an
association between the presence of DEHP in
dust and the prevalence of asthma in exposed
children has been suggested (Bornehag et al.
2004). Laboratory studies have shown that
many phthalate compounds administered to
mice by subcutaneous injection or by inhala-
tion exert an adjuvant effect on the immune
response to exposure to a coallergen (Hansen
et al. 2007; Larsen et al. 2001b, 2001a). After
stimulation with DEHP, murine T cells
respond with the enhanced production of
interleukin (IL)-4 (Lee et al. 2004), whereas
cultured neutrophils of both humans and
rodents exhibit an inflammatory response
(Gourlay et al. 2003). However, few human
exposure studies have addressed the effect of
phthalates in house dust on mucosal airway
response in humans. Tuomainen et al. (2006)
challenged 10 subjects experimentally to
degraded PVC products under controlled con-
ditions and found no differences in the
cytokine expression proﬁles in the nasal lavage
ﬂuid between challenge and control exposure,
concluding that PVC materials do not evoke
immediate asthmatic reactions. Further evi-
dence for direct health effects of inhalational
exposure to DEHP in humans is rare. In the
present study, we challenged healthy and aller-
gic human subjects with house dust containing
low (0.4 mg/g) and high (2.0 mg/g) concen-
trations of DEHP in a short-term exposure set-
ting. After nasal dust exposure, we analyzed
differences of the transcriptional and secretory
response of nasal mucosa using an oligonucleo-
tide cDNA microarray and a microsphere-
based ﬂow cytometric assay.
Materials and Methods
Subjects and eligibility. Sixteen healthy and
16 house dust mite (HDM)–allergic human
subjects participated in this exposure study.
Twenty subjects were male, and 12 were
female, with ages ranging from 22 to 32
(mean, 24) years. Subjects without clinically
relevant nasal disorders, except for allergic
subjects suffering from HDM allergy, were
eligible, as confirmed by rhinologic history
and nasal endoscopy. We identified HDM-
allergic subjects by skin prick test according
to the guidelines of the European Academy of
Allergy and Clinical Immunology (Dreborg
and Frew 1993): a CAP [or RAST (radioal-
lergosorbent test)] class of at least 3 (Phadia
AB, Uppsala, Sweden) and a positive nasal or
conjunctival provocation test (Riechelmann
et al. 2003b). Exclusion criteria were smok-
ing, pregnancy or lactation, allergy to aller-
gens other than HDM, a clinically relevant
nasal septal deviation or turbinate hypertro-
phy, rhinitis medicamentosa, chronic rhinosi-
nusitis, acute rhinosinusitis within the
preceding 6 weeks, previous sinus surgery,
bronchial hyperreactivity, lung emphysema,
and any systemic therapy with corticosteroids
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BACKGROUND: Few studies have yet addressed the effects of di(2-ethylhexyl) phthalate (DEHP) in
house dust on human nasal mucosa. 
OBJECTIVES: We investigated the effects of house dust containing DEHP on nasal mucosa of
healthy and house dust mite (HDM)–allergic subjects in a short-term exposure setting. 
METHODS: We challenged 16 healthy and 16 HDM-allergic subjects for 3 hr with house dust at a
concentration of 300 µg/m3 containing either low (0.41 mg/g) or high (2.09 mg/g) levels of
DEHP. Exposure to filtered air served as control. After exposure, we measured proteins and
performed a DNA microarray analysis. 
RESULTS: Nasal exposure to house dust with low or high DEHP had no effect on symptom scores.
Healthy subjects had almost no response to inhaled dust, but HDM-allergic subjects showed varied
responses: DEHPlow house dust increased eosinophil cationic protein, granulocyte-colony–stimulating
factor (G-CSF), interleukin (IL)-5, and IL-6, whereas DEHPhigh house dust decreased G-CSF and
IL-6. Furthermore, in healthy subjects, DEHP concentration resulted in 10 differentially expressed
genes, whereas 16 genes were differentially expressed in HDM-allergic subjects, among them anti-
Müllerian hormone, which was signiﬁcantly up-regulated after exposure to DEHPhigh house dust
compared with exposure to DEHPlow house dust, and ﬁbroblast growth factor 9, IL-6, and trans-
forming growth factor-β1, which were down-regulated. 
CONCLUSIONS: Short-term exposure to house dust with high concentrations of DEHP has attenuat-
ing effects on human nasal immune response in HDM-allergic subjects, concerning both gene
expression and cytokines.
KEY WORDS: allergy, cytokines, DEHP, di(2-ethylhexyl) phthalate, house dust, hypersensitivity,
microarray analysis, nasal challenge, nasal exposure system, nasal mucosa. Environ Health Perspect
116:1487–1493 (2008). doi:10.1289/ehp.11474 available via http://dx.doi.org/ [Online 7 July 2008]or anti-inflammatory drugs or nasal cortico-
steroid therapy within the preceding 6 weeks.
Our study was approved by the ethics com-
mittee of the University of Ulm, and each
participant gave written informed consent.
Study design. We randomly assigned sub-
jects to four groups exposed to house dust
with either low or high concentrations of
DEHP (Figure 1): We challenged eight
healthy and eight allergic subjects with
DEHPlow (0.41 mg/g) house dust, and eight
healthy and eight allergic subjects with
DEHPhigh (2.09 mg/g) house dust. We chal-
lenged each subject twice in a nose-only expo-
sure setting: once with the house dust in a
concentration of 300 µg/m3 for 3 hr, and
once with filtered air (control, 0 µg/m3) for
the same time period. The sequences of expo-
sures varied in a random order and were sin-
gle blinded. We kept a time interval of at least
14 days between the two exposures. We com-
pleted visual analogue scales (VASs) immedi-
ately before and after exposure. We collected
nasal ﬂuid on one nasal side 3 hr after the ﬁrst
exposure, and took a nasal biopsy on the
opposite side. After the second exposure, we
switched both sides.
Aerosol exposure. We generated aerosols
with a modiﬁed rotation plate aerosol generator
(Small Scale Powder Disperser, model 3433;
TSI GmbH, Aachen, Germany) (Riechelmann
et al. 2004). We dispersed the dust in condi-
tioned air (35% relative humidity, 21°C).
During the exposures, we constantly recorded
the accuracy of dust exposures employing a
laser particle counter (Microair-5230; Hiac
Royco, Leonberg, Germany).
House dust. We collected the house dust in
42 households using commercial vacuum
cleaners. We sieved the content of the vacuum
cleaner bags to a fraction of less than 32 µm
and then pooled and divided the dust in two
fractions. We used one fraction directly for
exposure (DEHPlow), and enriched the second
fraction with DEHPhigh in a rotary evaporator
(Rotavapor R-200; Buchi, Flawil, Switzerland).
Thus, the two house dust fractions were identi-
cal except for their content of DEHP. We
measured the concentrations of DEHP and
other phthalates by gas chromatography/mass
spectrometry (HP G1800A, GCD series II
MS; Agilent Technologies, Santa Clara,
California, USA) (Butte et al. 2001).
We determined concentrations of several
indoor allergens, including Der p1, Der f1,
and Fel d1, with the Dustscreen immunodot
assay (CMG Heska, Fribourg, Switzerland).
We detected the presence of grass, alder,
birch, and yew pollen by light microscopy.
Measurements of polycyclic aromatic hydro-
carbons, polychlorinated biphenyls, biocides,
phenols, heavy metals, tensides, and other
contaminants are described elsewhere
(Riechelmann et al. 2007).
Symptom scores. Before and immediately
after each exposure, the subjects estimated
their sensation of nasal obstruction, hyper-
secretion, dryness, itching, and sneezing,
mucous membrane burning and unpleasant
smell on a 10-cm-long horizontal VAS. We
measured the distance from the left border of
the scale to the marks made by the subjects in
millimeters and calculated the difference after
versus before exposure. Positive values indicate
a degradation of the appropriate symptom
after challenge compared with the control.
Nasal secretions and biopsy. At 3 hr post-
exposure, an open-cell flexible polyurethane
foam sampler of 28 × 18 × 6 mm was placed
into one nasal cavity posterior to the muco-
cutaneous junction under direct visualization
and left in place for 10 min. After removal,
we extracted the secreted ﬂuid from the sam-
pler by centrifugation and stored it at –20°C
(Riechelmann et al. 2003a). On the opposite
side, we took a nasal inferior turbinate biopsy
under local anesthesia with a Fokkens forceps
(Explorent, Tuttlingen, Germany).
Cytokines and eosinophil cationic protein.
We diluted nasal secretions 1:10 and analyzed
cytokine concentrations on a Bio-Plex
Suspension Array System (Bio-Rad Labora-
tories, Munich, Germany) for IL-2, IL-4,
IL-5, IL-6, IL-8, interferon-γ (IFNγ), and
granulocyte-colony–stimulating factor
(G-CSF) employing a multiplex cytokine assay
for seven cytokines (Bio-Rad Laboratories)
with the Bio-Plex Manager Software 3.0 (Bio-
Rad Laboratories). We measured eosinophil
cationic protein (ECP) using a fluorescence
enzyme immunoassay with the UniCAP 100
Diagnostic System (Phadia, Freiburg,
Germany). We performed all assays according
to the manufacturers’ recommendations.
DNA microarray analysis. We performed
intraindividual differential (control vs. house
dust exposure) gene expression analysis from
four subjects of each exposure group. We ran-
domly selected subjects for microarray analysis.
The cDNA microarray consisted of 1,232
human genes, 10 different extrahuman spiking
controls from Arabidopsis and Sinorhizobium
genes, and randomized negative controls (i.e.,
oligonucleotides that do not bind human
mRNA) in 300 and in 12 spot quadruples as
described previously (Riechelmann et al. 2007).
Briefly, we spotted oligomers (Operon
Biotechnologies, Cologne, Germany) on Ultra
Gaps 2 coated slides (Corning, Schiphol-Rijk,
The Netherlands). We isolated total RNA from
biopsy specimens using the RNeasy Mini Kit
(Qiagen, Cologne, Germany). For spiking con-
trols, we synthesized synthetic mRNA of
10 different Arabidopsis and Sinorhizobium
genes on an ABI 394 synthesizer (Purimex,
Staufenberg, Germany). We added 0.2–10 pg
of this spiking mRNA to the total RNA of con-
trol and exposure specimens, resulting in ratios
of 1:2 to 1:10. We reverse transcribed mRNA,
labeled it using Superscript-2 (Invitrogen,
Karlsruhe, Germany) in combination with the
3 DNA Array 350 Kit (Genisphere, Hatﬁeld,
PA, USA), and hybridized it with the spotted
oligonucleotides at 57°C overnight. We
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Figure 1. Study ﬂow chart. Healthy and HDM-allergic subjects were randomly arranged for challenge with
either DEHPlow or DEHPhigh house dust and the sequence of dust (300 μg/m3) and control (ﬁltered air, 0 μg/m3)
exposure.
32 subjects
16 healthy subjects
16 allergic subjects
8 subjects
DEHPlow
8 subjects
DEHPhigh
8 subjects
DEHPlow
8 subjects
DEHPhigh
4 × exposure
sequence 0–300
4 × exposure
sequence 300–0
4 × exposure
sequence 0–300
4 × exposure
sequence 300–0
4 × exposure
sequence 0–300
4 × exposure
sequence 300–0
4 × exposure
sequence 0–300
4 × exposure
sequence 300–0scanned microarrays with a dual-laser micro-
array scanner (GenePix 4000 B; Axon
Instruments, Foster City, CA, USA) recorded
with GenePix Pro 4.1 software (Axon
Instruments) and carried out further analysis
using the platform-independent java applica-
tion ArrayNorm, version 1.7.2 (Pieler et al.
2004). After background subtraction and
Lowess subgrid normalization, we performed
replicate handling as we averaged quadrupled
spots within a slide. Accordingly, we calculated
the log2-transformed cyanine 5:cyanine 3 ratio
(log2-expression ratio) for all genes and con-
trols. We identified differentially expressed
genes between DEHPlow and DEHPhigh expo-
sure using Student’s t-test with Bonferroni step-
down correction to adjust the critical alpha
limit of 0.05. We considered only genes with
valid expression values in each biologic replicate
for analysis. We annotated genes according the
glossary of the Human Genome Organisation
(HUGO) (Wain et al. 2004). The full list of
array data is available on the server of the Ear,
Nose, and Throat Department Ulm (2008).
Statistical analysis. For VASs, we calcu-
lated changes before and after exposure with
the Wilcoxon signed rank test. For protein
concentrations, we calculated and tabulated
the median and interquartile range (IQR). We
calculated dependent samples using the
Wilcoxon signed rank test, and independent
samples with the Mann–Whitney U-test. We
considered a p-value < 0.05 to be signiﬁcant.
We performed calculations using Systat 10.2
(Systat Software, Point Richmond, CA, USA).
Results
House dust. The concentration of DEHP in
the DEHPlow house dust fraction was
0.41 mg/g. Enrichment of house dust with
DEHP yielded to a 5-fold higher concentra-
tion of 2.09 mg/g in the DEHPhigh fraction.
Table 1 lists the amounts of phthalates, major
allergens, fungal spores, and endotoxin activ-
ity. Pollen from weeds, alder, birch, and yew
were identiﬁed but not quantiﬁed.
Symptom scores. Nasal exposure to
DEHPlow or DEHPhigh house dust did not
cause significant changes in nasal symptom
scores concerning dryness, itching and sneez-
ing, mucous membrane burning, and unpleas-
ant smell compared with ﬁltered air exposure
(Table 2). HDM-allergic subjects complained
about nasal obstruction and hypersecretion
after exposure to DEHPlow house dust, but
this effect was not signiﬁcant (p > 0.05).
Cytokines and ECP. Sampling of epithelial
lining ﬂuid with a polyurethane foam sampler
from all subjects yielded to a median volume
of 275 µL (IQR, 180–450 µL). Table 3 out-
lines the results of protein determination.
Independent from exposure to DEHPlow
or DEHPhigh house dust, we found no signiﬁ-
cant changes in the concentrations of cytokines
and ECP in nasal secretions in healthy subjects.
Nasal challenge of eight HDM-allergic subjects
with DEHPlow house dust resulted in signiﬁ-
cantly elevated median concentrations of ECP
(p = 0.01), G-CSF (p = 0.02), IL-5 (p = 0.03),
and IL-6 (p = 0.02) in nasal secretions com-
pared with the appropriate control exposure
with ﬁltered air (Figure 2). The eight HDM-
allergic subjects that we challenged with
DEHPhigh house dust showed significantly
Nasal immune response to DEHP in allergic subjects
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Table 1. Phthalates, major allergens, fungal spores, and endotoxin activity in house dust.
Compound or allergen Mean ± SD
Phthalic acid esters (phthalates) (mg/kg)
n-Butyl benzyl phthalate (BBzP) 34.0 ± 4.05
Diisobutyl phthalate (DiBP) 31.7 ± 3.36
Di-n-butyl phthalate (DnBP) 49.2 ± 5.7
Diethyl phthalate (DEP) 44.5 ± 4.17
Dimethyl phthalate (DMP) 0.42 ± 0.04
Di-n-octyl phthalate (DnOP) 4.23 ± 0.44
Major allergens (μg/g)
Der p1 2.0 ± 0.1
Der f1 2.0 ± 0.1
Fel d1 5.4 ± 0.5
Fungal spores (cfu/g)
Penicillium spp. 72,000 ± 6,200
Aspergillus spp. 8,000 ± 720
Endotoxin activity (EU/g) 15.8 ± 0.6
cfu, colony-forming units.
Table 2. Symptom scores (10-cm-long horizontal VAS) after nasal challenge with house dust: difference
[median (IQR)] after compared with before exposure.
DEHPlow house dust DEHPhigh house dust
Symptom Control Exposure Control Exposure
Healthy subjects (n = 16)
OBS –0.5 (–0.85 to 0.1) 0 (–0.3 to 0.9) –0.65 (–1.25 to 2.95) –0.6 (–0.95 to 0.25)
HS –0.65 (–1.45 to 0.05) –0.9 (–1.7 to–0.4) –0.95 (–2.35 to 0.05) –0.1 (–1.7 to 0.05)
IS 0 (0 to 0.35) –0.05 (–0.4 to 0) –0.3 (–1.85 to 0.05) 0 (–0.05 to 0.35)
DRY 0.05 (–0.1 to 0.2) 0.45 (0.2 to 2.35) 1.3 (0.25 to 4) 1.55 (0.3 to 3.2)
SME 0.1 (0 to 0.25) 0.1 (–0.05 to 1.45) 0.05 (–0.05 to 2.05) 0.1 (–0.05 to 2.05)
BUR 0.05 (0 to 0.15) 0.2 (0 to 1.1) 0 (–0.1 to 0.6) 0 (–0.15 to 0.1)
HDM-allergic subjects (n = 16)
OBS 0.05 (–0.75 to 0.45) 1.4 (0.35 to 2.1) 0.15 (–0.25 to 2.35) –0.15 (–0.75 to 2.6)
HS –0.45 (–1.3 to 0.1) 0.9 (–0.25 to 2.3) –0.05 (–1.25 to 0.7) –0.15 (–1.05 to–0.05)
IS 0 (–0.4 to 0) 0.05 (–0.1 to 0.5) 0.6 (–0.55 to 2.1) 0.75 (–0.05 to 2.35)
DRY 0.2 (–1.15 to 2.6) 1.15 (–0.1 to 3.45) –0.15 (–1.05 to 3.15) 0.3 (–0.8 to 4.7)
SME 0.05 (–0.1 to 0.1) 0.1 (0 to 1.9) 0.2 (0 to 1.55) 0.2 (0 to 2.05)
BUR 0.05 (0 to 0.15) 0 (–0.05 to 0.1) 0.1 (–0.05 to 0.8) 0.1 (–0.05 to 0.65)
Abbreviations: BUR, mucous membrane burning; HS, hypersecretion; IS, itching and sneezing; DRY, dryness; OBS, sensa-
tion of nasal obstruction; SME, unpleasant smell.
Table 3. Concentrations of proteins in the epithelial lining ﬂuid of 16 healthy and 16 HDM-allergic subjects
after nasal challenge with house dust [median (IQR), rounded to whole numbers].
DEHPlow house dust DEHPhigh house dust
Protein Control Exposure Control Exposure
Healthy subjects (n = 16)
G-CSF 1,351 (1,049–1,690) 817 (465–2,765) 1,900 (1,128–3,198) 1,656 (319–2,116)
IFNγ 130 (78–180) 147 (119–188) 129 (84–209) 152 (105–230)
IL-2 34 (13–48) 34 (19–59) 19 (4–41) 33 (14–63)
IL-4 118 (66–136) 126 (91–145) 105 (84–138) 117 (79–133)
IL-5 4 (3–41) 5 (2–7) 9 (3–26) 7 (4–15)
IL-6 744 (455–1,201) 572 (289–1,005) 707 (481–1,048) 506 (426–660)
IL-8 1,838 (1,300–2,507) 1,882 (811–2,612) 2,172 (1,165–2,802) 1,402 (1,208–2,114)
ECP (ng/mL) 57 (32–96) 54 (10–156) 60 (10–233) 95 (21–242)
HDM-allergic subjects (n = 16)
G-CSF 793 (313–5,069) 2,165 (482–12,599) 873 (276–4,548) 925 (364–2,432)
IFNγ 99 (78–245) 154 (42–2,497) 139 (47–304) 121 (74–282)
IL-2 30 (9–43) 48 (3–357) 43 (9–107) 28 (9–105)
IL-4 88 (54–153) 121 (66–593) 82 (26–162) 94 (48–156)
IL-5 7 (3–26) 24 (3–195) 16 (4–122) 12 (2–30)
IL-6 373 (232–1,255) 754 (570–1,685) 510 (157–1,537) 332 (113–575)
IL-8 1,835 (971–5,081) 2,778 (788–5,092) 1,611 (661–2,474) 1,851 (563–4,111)
ECP (ng/mL) 57 (2–465) 115 (13–690) 62 (15–327) 106 (19–303)
Values are pg/mL, except where indicated.lower concentrations of G-CSF and IL-6 in
nasal secretions than did the HDM-eight aller-
gic subjects we challenged with DEHPlow
house dust (G-CSF, p = 0.04; IL-6, p = 0.001)
(Figure 3). We found no signiﬁcant changes
for the other cytokines or for ECP.
DNA microarray gene expression analysis.
After control and dust exposures, we obtained
nasal mucosa biopsies using the Fokkens for-
ceps from all participants. The median
amount of extracted total RNA from biopsy
material was 10.1 µg (IQR, 7.8–13.2 µg).
We performed gene expression analysis from
four subjects of each exposure group. Because
of insufficient hybridization quality, we
excluded two microarrays from HDM-allergic
subjects from further evaluation.
In healthy subjects, we found 10 genes
(0.8% of 1,232 genes) to be differentially
expressed between the two exposure groups
(Table 4). Chemokine (C-C motif) ligand 19
[CCL19, UniGene ID NM_006274 (UniGene,
http://www.ncbi.nlm.nih.gov/sites/entrez?db=
unigene)], a chemokine also known as macro-
phage inflammatory protein-3β (MIP-3β),
showed higher expression in healthy subjects
after nasal challenge with DEHPhigh house
dust compared with exposure to DEHPlow
house dust (mean log2-expression ratio differ-
ence = 0.648; p = 0.017).
In HDM-allergic subjects, we found 16
genes (1.3% of 1,232 genes) to be differen-
tially expressed between the two exposure
groups (Figure 4). We identiﬁed eight genes,
among them anti-Müllerian hormone (AMH,
UniGene ID NM_000479), whose expression
was significantly higher after exposure to
DEHPhigh house dust compared with expo-
sure to DEHPlow house dust (mean log2-
expression ratio difference = 0.871; p = 0.019).
We found eight genes whose expression was
significantly lower, among them fibroblast
growth factor 9 (FGF9, NM_002010; 0.975,
p = 0.016), lactate dehydrogenase A (LDHA,
NM_005566; 1.237, p = 0.013), and the
cytokines IL-6 (IL6, NM_000600; 0.916, p =
0.009) and transforming growth factor-β1
(TGFB1, NM_000660; 0.621, p = 0.019).
Discussion
In this study, we investigated the effects of
house dust with low and high concentrations
of DEHP on nasal mucosa of healthy and
HDM-allergic human subjects in a short-
term exposure setting. Corresponding para-
meters included a transcriptional profile of
1,232 genes and the concentrations of several
cytokines and ECP in nasal secretions. We
found two overall results: a) Healthy subjects
were not significantly affected by the chal-
lenge with house dust, and b) HDM-allergic
subjects perceived little of the challenge, and
low concentrations of DEHP induced a silent
inflammation in human nasal mucosa.
However, high concentrations of DEHP
attenuated the immune response based on
protein and mRNA levels.
We collected and pooled house dust from
42 German homes to provide a reasonably
representative sample. Coarse particles with
diameters > 10 µm are deposited predomi-
nantly in the upper airways (Keck et al. 2000).
Hence, we used the selected fraction with
coarse particles < 32 µm for exposure. A dust
concentration of 300 µg/m3 is equal to that in
interiors with human activity (Junker et al.
2000), in ofﬁces (Molhave et al. 2004), and in
public transportation (Praml and Schierl
2000). Because of its ubiquity, DEHP appears
in almost every house dust sample. Dust sam-
ples collected in office buildings in Austria
showed DEHP concentrations ranging up to
3 mg/g (Hutter et al. 2006). The median con-
centration of DEHP in dust collected in chil-
dren’s bedrooms in 346 homes in Sweden was
0.7 mg/g (Bornehag et al. 2004). These con-
centrations resemble the concentrations of
0.41 mg/g and 2.09 mg/g used in our study,
which consequently agree with DEHP con-
centrations naturally occurring in house envi-
ronments. The content of the major allergens
Der p1 and Der f1 in house dust depends of
several factors, such as geographic region, sea-
sonal variation, climate conditions, age of the
dwelling, and ﬂoor covering. In dwellings in
the Netherlands, van Strien et al. (1994)
found a mean Der p1 concentration of
2.4 µg/g for ﬂoor dust from living rooms, but
Deutschle et al.
1490 VOLUME 116 | NUMBER 11 | November 2008 • Environmental Health Perspectives
Figure 2. Concentrations of ECP (A), G-CSF (B), IL-5 (C), and IL-6 (D) in nasal secretions after nasal expo-
sure of eight HDM-allergic subjects to DEHPlow house dust compared with their control exposure to
filtered air. p-Values calculated with the Wilcoxon signed rank test: ECP, p = 0.01; G-CSF, p = 0.02; IL-5,
p = 0.03; IL-6, p = 0.02. Horizontal line, median; box contains the central 50% of values; whiskers, observed
values; circle, far outside values; asterisk, inner values.
700
600
500
400
300
200
100
0
Control 300 μg/m3
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
p
g
/
m
L
)
Control 300 μg/m3
15,000
10,000
5,000
0
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
p
g
/
m
L
) *
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
p
g
/
m
L
)
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
p
g
/
m
L
)
2,000
1,500
1,000
500
0
200
150
100
50
0
Control 300 μg/m3 Control 300 μg/m3
A B
C D
*
Figure 3. Concentrations of G-CSF (A) and IL-6 (B) in nasal secretions after nasal challenge of HDM-
allergic subjects with DEHPlow or DEHPhigh house dust. p-Values calculated with the Mann–Whitney
U-test: G-CSF, p = 0.04; IL-6, p = 0.001. Horizontal line, median; box contains the central 50% of values;
whiskers, observed values; asterisk, inner values.
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*in more than the half of the houses the maxi-
mum concentration exceeded 10 µg/g.
However, the mean concentration of 0.09
µg/g (range, < 0.01–9.54 µg/g) Der p1 found
in European homes within the European
Community Respiratory Health Survey II is
several times lower (Zock et al. 2006).
Differences in allergen contents in dust sam-
ples may be caused by different dust collecting
methods (Schram-Bijkerk et al. 2006). Our
house dust was collected over at least 4 weeks
in the whole dwelling with conventional vac-
uum cleaners, provided by the inhabitants
themselves. When we used multilayered vac-
uum cleaner bags, we also included the fine
dust fraction between the unique paper layers.
It is possible that the long sampling time and
dust extracted from the whole vacuum cleaner
bag yielded Der p1 and Der f1 concentrations
of 2.0 µg/g each, representing typical concen-
trations in house dust samples from common
households. Endotoxin levels resembled con-
centrations found in a recent European study
(Bouillard et al. 2006).
Study subjects’ nasal symptom severity is
an important outcome measure in the assess-
ment of dust-induced effects. Symptom scores
based on VAS are being used increasingly for
this purpose. Concerning healthy volunteers,
no upper or lower respiratory symptoms were
described after challenge with concentrated
ambient air particles (23.1–311.1 µg/m3)
(Ghio et al. 2000) or urban dust (150 and
500 µg/m3) (Riechelmann et al. 2004).
However, upper respiratory symptoms were
not associated with plastic wall materials
(Jaakkola et al. 2000). As expected, house dust
did not affect nasal function in our healthy
subjects irrespective of the administered
DEHP concentration. Although our HDM-
allergic subjects had positive nasal or conjunc-
tival provocation tests, nasal challenge with
house dust did not result in distinct allergic
symptoms. Apparently, the concentration of
house dust and the afﬁliated allergen dose was
too low to elicit nasal symptoms. Particularly
in persistent allergic rhinitis, affected subjects
can habituate to allergen and remain asympto-
matic. Among our HDM-allergic subjects, we
found a faint but nonsignificant association
with increased nasal obstruction and hyper-
secretion for DEHPlow house dust but not for
DEHPhigh house dust. Phthalates and their
metabolites have the potential to interact with
the immune system. Concentration-depen-
dent effects of some phthalates are described
in animal and in vitro studies. In general,
lower concentrations of phthalates have shown
stimulatory and higher concentrations sup-
pressive properties (Jepsen et al. 2004; Larsen
Nasal immune response to DEHP in allergic subjects
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Table 4. Genes differentially expressed between DEHPlow and DEHPhigh house dust exposure in nasal mucosa of healthy subjects (individual subject values and
group means).
Log2-expression ratio for house dust challenge 
DEHPlow DEHPhigh Difference
HUGO name 24 31 36 40 Mean 22 25 26 34 Mean of means p-Value
CCL19 (*) –0.412 0.182 0.417 –0.040 0.037 0.705 0.211 0.812 0.714 0.611 0.648 0.017
CREBL1 (*) –0.129 –0.073 –0.274 0.619 0.036 0.517 1.029 1.559 0.787 0.973 1.009 0.018
RCN1 (*) 0.955 –0.530 0.085 0.125 0.159 2.200 1.942 1.348 0.430 1.480 1.639 0.024
SON (*) 0.077 0.055 0.116 –0.370 –0.031 1.504 1.106 1.733 0.929 1.318 1.349 0.002
TNFSF10 (*) –0.269 –0.201 0.372 –1.115 –0.303 0.621 0.975 0.603 0.266 0.616 0.919 0.012
XCR1 (*) –0.255 0.243 –0.318 –0.319 –0.162 1.695 0.785 1.714 1.294 1.372 1.534 0.002
CDKN2B 0.339 0.087 0.076 0.176 0.170 –0.051 –0.074 –0.008 0.036 –0.024 0.194 0.016
FCGBP 0.810 0.472 0.794 –0.079 0.499 –0.075 –0.612 –0.152 –0.269 –0.277 0.776 0.010
GPX1 0.076 0.056 0.113 0.098 0.086 0.065 0.039 –0.004 –0.044 0.014 0.100 0.018
USP20 –0.085 0.168 0.481 0.331 0.224 –0.636 –0.150 –0.842 –1.592 –0.805 1.029 0.005
Abbreviations: CCL19, chemokine (C-C motif) ligand 19 (UniGene ID NM_006274); CDKN2B, cyclin-dependent kinase inhibitor 2B (NM_078487); CREBL1, cAMP responsive element bind-
ing protein-like 1 (NM_004381); FCGBP, Fc fragment of IgG binding protein (NM_003890); GPX1, glutathione peroxidase 1 (NM_000581); RCN1, reticulocalbin 1, EF-hand calcium binding
domain (NM_002901); SON, SON DNA binding protein (NM_058183); TNFSF10, tumor necrosis factor (ligand) superfamily, member 10 (NM_003810); USP20, ubiquitin speciﬁc peptidase 20
(NM_006676); XCR1, chemokine (C motif) receptor 1 (NM_005283). Genes marked with (*) were up-regulated after challenge with DEHPhigh house dust compared with the challenge with
DEHPlow house dust; the other genes were down-regulated. Values are log2-expression ratios, means, and differences in means; p-values are for Student’s t-test with Bonferroni step-
down correction; gene names are abbreviations of the Human Genome Organization (HUGO).
Figure 4. Differentially expressed genes in nasal mucosa of six HDM-allergic subjects exposed to DEHPlow
(white bars) or DEHPhigh (black bars) house dust. Values are mean fold difference in log2-expression
ratios; p < 0.05 for all genes. Gene names are abbreviations of the Human Genome Organization (HUGO):
AMH, anti-Müllerian hormone (NM_000479); CD83, CD83 molecule (NM_004233); CEACAM4, carcinoem-
bryonic antigen-related cell adhesion molecule 4 (NM_001817); CREBBP, CREB binding protein
(Rubinstein-Taybi syndrome) (NM_004380); ERBB3, v-erb-b2 erythroblastic leukemia viral oncogene
homolog 3 (NM_001982); ESD, esterase D/formylglutathione hydrolase (NM_001984); FGF9, fibroblast
growth factor 9 (glia-activating factor) (NM_002010); GNAT1, guanine nucleotide binding protein (G pro-
tein), alpha transducing activity polypeptide 1 (NM_000172); HLADPA1, major histocompatibility complex,
class II, DP alpha 1 (NM_033554); IL6, IL-6 (NM_000600); ITGB5, integrin, beta 5 (NM_002213); KRT17, ker-
atin 17 (NM_000422); LDHA, lactate dehydrogenase A (NM_005566). NTRK3, neurotrophic tyrosine kinase,
receptor, type 3 (NM_002530); RORA, RAR-related orphan receptor A (NM_002943); TGFB1, transforming
growth factor, beta 1 (NM_000660).
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DEHPhighet al. 2002). The effect of DEHP on nasal
symptoms of HDM-allergic subjects may be
concentration dependent.
Potential adverse effects of phthalates arise
from their developmental and reproductive
toxicity, particularly in males (Howdeshell
et al. 2007). Phthalates act as endocrine disrup-
tors because they alter the hormone proﬁles of
both sexes by interfering with estrogen- or
androgen-signaling mechanisms (Ma et al.
2006; Sharpe and Irvine 2004). In a human
breast cancer cell line, DEHP mimicked estro-
gen in the inhibition of tamixofen-induced
apoptosis (Kim et al. 2004), and it acts as an
anti-androgen in rats (Andrade et al. 2006).
AMH is a member of the transforming growth
factor-β (TGFB) family that is implicated in
the regression of Müllerian ducts in male
fetuses and in the development and function of
gonads. Currently, AMH is not suspected to
play a major role in endocrine disruption
(Sharpe 2006). However, in HDM-allergic
subjects, transcription of AMH increased sig-
nificantly after exposure to DEHPhigh house
dust compared with DEHPlow house dust. It
remains unknown whether DEHP affects tran-
scription of AMH in nasal mucosa tissue via an
androgen or estrogen receptor mechanism or
some other pathway. Some more interesting
observations include the down-regulation of
LDHA and FGF9 in HDM-allergic subjects
after exposure to DEHPhigh house dust. Both
genes are involved in sex determination. In the
testes of rats, gene expression of LDHA is
down-regulated after phthalate exposure
in utero (Plummer et al. 2007) and FGF9 plays
distinct roles in testis development and male
sex determination (Colvin et al. 2001). In fact,
the potential adverse effects of DEHP have not
yet been elucidated in detail. But DEHP
is known to be a modulator of gene expression
in human cells (Hokanson et al. 2006).
Peroxisome-proliferator–activated receptor-α
(PPARα) is a member of the nuclear receptor
superfamily. Its activation can result in poten-
tial anti-inflammatory effects by repressing
nuclear factor-κB (NF-κB) (Mandard et al.
2004). Metabolites of DEHP act as ligands of
PPARα (Ward et al. 1998). Thus, DEHP may
interact with NF-κB via the PPARα-pathway,
thereby down-regulating gene expression.
As mentioned above, the effects of some
phthalates on immune responses are dose
dependent, with adjuvant and suppressive
properties in lower and higher concentrations,
respectively. Larsen and colleagues demon-
strated the adjuvant effect of DEHP after
simultaneously administered ovalbumin, indi-
cating that DEHP is a mixed T-helper cell type
1/2 adjuvant (Larsen and Nielsen 2007), but
nonoccupational, realistic levels of DEHP nei-
ther revealed an adjuvant effect nor induced
allergic lung inﬂammation in mice (Larsen et al.
2007). Our HDM-allergic subjects revealed no
significant nasal symptoms after exposure to
DEHPhigh house dust, but the cytokine expres-
sion profile changed. We found increases in
ECP, G-CSF, IL-5, and/or IL-6 after exposure
to DEHPlow house dust. After exposure to
DEHPhigh house dust ECP, G-CSF, IL-5,
and/or IL-6 were not increased. Additionally,
G-CSF and particularly IL-6 decreased signiﬁ-
cantly after exposure to DEHPhigh house dust,
pointing toward an attenuated immune
response at high concentrations of DEHP in
house dust. It is not clear from the data in this
study whether the applied range of exposure
causes a linear or nonlinear attenuation because
this study used a three-point design with no
exposure (control), DEHPlow house dust, and
DEHPhigh house dust. This could be addressed
by future studies by having several levels of
exposure within a certain range.
As detailed above, a plausible molecular
mechanism for the attenuating effects of
DEHP is the repression of transcription fac-
tor NF-κB. Like DEHP, volatile organic
compounds may attenuate the immune
response (Wichmann et al. 2005). We found
the same diminished release of cytokines after
exposure to house dust with high concentra-
tions of DEHP as was found for thalidomide
(α-N-phthalimidoglutarimide), a sedative
with related chemical structure and terato-
genic properties (Rowland et al. 1998).
However, thalidomide does not act directly
on NF-κB (Rowland et al. 2001). These
observations do not exclude a possible associa-
tion between exposure to DEHP and sup-
pressed gene expression via the NF-κB
pathway, because the metabolites of DEHP,
and not DEHP itself, interact with NF-κB. 
The results of our gene expression analysis
indicate an altering effect of DEHP on gene
expression in human nasal mucosa. The
changes demonstrated for IL-6 on the protein
level are consistent with the results of gene
expression analysis observed in HDM-allergic
subjects: IL-6 was up-regulated after exposure
to DEHPlow house dust and down-regulated
after exposure to DEHPhigh (Figure 4). We did
not detect transforming growth factor-β1
(TGF-β1) protein, but transcription of
TGFB1 decreased signiﬁcantly after exposure
of HDM-allergic subjects to DEHPhigh house
dust. TGF-β1 is an anti-inflammatory cyto-
kine with comparatively high concentrations in
healthy mucosa but decreased concentrations
in allergic inﬂammation (Benson et al. 2002).
Hence, it remains unknown whether the
decrease in TGFB1 transcription is related to
the fact that DEHP attenuates the immune
response or to the fact that TGF-β1 is already
decreased in allergy mucosa.
Conclusions
In conclusion, our study provides the ﬁrst results
of short-term exposure to house dust containing
low and high concentrations of DEHP on nasal
mucosa of healthy and HDM-allergic human
subjects. Healthy subjects were not affected by
the dust exposures. Low doses of DEHP in
house dust elicited a silent inﬂammation in nasal
mucosa of HDM-allergic subjects on both the
protein and mRNA level. High concentrations
of DEHP in house dust attenuated this inﬂam-
mation. Our results suggest a stimulating effect
at low doses of DEHP and an attenuating effect
at high doses. However, exposing adults for 3 hr
in a short-term exposure setting is very different
from long-term exposure of children to house
dust and phthalates in their homes; these two
populations may exhibit true differences in
immunologic reactions.
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